Metabolomic Profile in Venous Thromboembolism (VTE)
Open Access
- 29 July 2021
- journal article
- review article
- Published by MDPI AG in Metabolites
- Vol. 11 (8), 495
- https://doi.org/10.3390/metabo11080495
Abstract
Venous thromboembolism (VTE) is a condition comprising deep venous thrombosis (DVT) and pulmonary embolism (PE). The prevalence of this disease is constantly increasing and it is also a chief reason for morbidity. Therefore, the primary prevention of VTE remains a highly important public health issue. At present, its diagnosis generally relies on subjective clinical examination and ultrasound imaging. D-dimer is also used as a biomarker, but it is considered to be poorly specific and only moderately sensitive. There are also no reliable methods that could accurately guide the type of treatment and potentially identify patients who may benefit from more aggressive therapies without the risk of bleeding. The application of metabolomics profiling in the area of vascular diseases may become a turning point in early diagnosis and patient management. Among the most described metabolites possibly related to VTE are carnitine species, glucose, phenylalanine, 3-hydroxybutarate, lactic acid, tryptophan and some monounsaturated and polyunsaturated fatty acids. The cell response to acute PE was suggested to involve the uncoupling between glycolysis and oxidative phosphorylation. Despite technological advancement in the identification of metabolites and their alteration in thrombosis, we still do not understand the mechanisms and pathways responsible for the occurrence of observed alterations.This publication has 103 references indexed in Scilit:
- Serum sphingolipids level as a novel potential marker for early detection of human myocardial ischaemic injuryFrontiers in Physiology, 2013
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signalingCellular Signalling, 2012
- Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYCProceedings of the National Academy of Sciences of the United States of America, 2012
- Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivoThe Journal of Experimental Medicine, 2012
- The human circadian metabolomeProceedings of the National Academy of Sciences of the United States of America, 2012
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseNature, 2011
- Adenosine and blood plateletsPurinergic Signalling, 2011
- The logic of the hepatic methionine metabolic cycleBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- Application of Metabolomics to Cardiovascular Biomarker and Pathway DiscoveryJournal of Invasive Cardiology, 2008
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008